Top Stories

Published on Tuesday, February 26, 2019

The Alpha-1 Foundation gears up for the 2019 Global meetings in Dubrovnik, Croatia

The Alpha-1 Foundation gears up for the 2019 Global meetings in Dubrovnik, Croatia

MIAMI, Feb. 26th, 2019 - The 7th Alpha-1 Global Patient Congress and 4th International Research Conference on Alpha-1 Antitrypsin will be held April 3-6, at the Sheraton Dubrovnik Riviera Hotel in Dubrovnik, Croatia. Patient leaders, physicians and scientists from around the world will come together to discuss the latest developments in patient advocacy, clinical care and Alpha-1 Antitrypsin Deficiency (Alpha-1) research. 

With a rich history of international collaboration, the Foundation is committed to Alphas worldwide and is proud to host representatives from 32 countries. Through the dedication of the Conference Planning Committee, we are looking forward to another outstanding event. The commitment to the mission drives the Alpha-1 Global program each day, to increase awareness, detection, and access to care for Alphas around the world.  

“The recent changes in the Alpha-1 Global program offers me the opportunity to reshape our outreach to the entire Alpha-1 community, globally. Our strategic alliances are strong and will be reaffirmed in Dubrovnik, Croatia, at our International Scientific Conference and concurrent International Patient Congress. I would like to extend my gratitude to the Internal Conference Planning Committee, Richard Lovrich, who will be our emcee, and the Foundation’s hardworking staff and volunteers,” expressed Miriam O’Day, president and CEO of the Alpha-1 Foundation.

“These events will be the first international meetings I have attended since our meeting in Barcelona, in 2013. This is an exciting opportunity to be able to collaborate and strategize about the future of the Global program in my new role as president and CEO,” she added.

The 2019 meeting will begin with the 4th International Research Conference on Wednesday and Thursday, April 3-4. The Research Conference theme titled “Beyond Folding: Disease Progression and Therapeutic Options” is chaired by Professor Rob Stockley from University Hospitals Birmingham, United Kingdom. 

The program agenda for the 4th International Research Conference is available to view here

We will continue with representatives from 32 countries at the Global Patient Congress with a welcome reception and networking dinner where Alpha-1 patients, physicians and researchers can interact on Thursday, April 4th. The patient congress will continue Friday and Saturday, April 5-6.

The program agenda for the 7th Alpha-1 Global Patient Congress is available to view here

A special thank you to our outstanding Global Conference Planning Committee and Global Advisory Committee:

  • Cristina Barbiero, National Association Alfa-1 AT Italy, EU Advocacy Working Group, Italy
  • Jim Clarke, Alpha-1 Association New Zealand Co-Leader Alpha-1 Support Group, New Zealand
  • Shane Fitch, Lovexair Foundation - President, Spain
  • Elena Goyanes, Alpha-1 Association Spain, EU Advocacy Working Group, Spain
  • Karen O'Hara, Alpha-1 UK Support Group - ERN - Lung, EARCO, UK
  • Carlos Cambon, Alpha-1 Association Argentina, Argentina  
  • Martina Cambon, Alpha-1 Association Argentina, Argentina
  • Frank Willersinn, MD, Alpha-1 Plus, Belgium
  • Marion Bouchecareilh, University of Bordeaux, Alpha-1 Liver Research, France
  • Robert Durlik, Alpha-1 Poland, Founder, Poland
  • Robert Kroesen, Patient Representative, Panama
  • Tim Frost, AlphaNet Board Member, USA

Global Advisory Committee: 

  • Jeanine D’Armiento, MD, PhD, Alpha-1 Foundation – Chair, USA
  • Robert Sandhaus, MD, PhD, FCCP, Alpha-1 Foundation Medical Director, USA
  • Robert Stockley, MD, Director Lung Immuno Biochemical Research Laboratory, UK
  • Adam Wanner, MD, Alpha-1 Foundation Scientific Director, USA

The Alpha-1 Foundation graciously thanks the 2019 Alpha-1 Global Patient Congress and Research Conference Sponsors. Presenting Sponsors: AlphaNet, CSL Behring and Grifols. Gold Sponsors: Arrowhead, Kamada and Vertex. Bronze Sponsors: Dicerna and Mereo BioPharma.


For additional information on the upcoming events, please contact Randel Plant, global programs manager, or 877-228-7321 ext. 306.

For hotel and travel arrangements, please contact Adriana De Arce, manager of scientific events, or 877-228-7321 ext. 269.


New US website on Disabilities and Health

Monday, July 26, 2010
The US Centers for Disease Control (CDC) has a new Disabilities and Health website. Some of the new features of the site include: Easy-to-read information on healthy living, secondary conditions, accessibility, and emergency...

"Bad Blood" film documents tragedy of tainted US blood supply in 1970s-1990s

Monday, July 26, 2010
New York, NY – The documentary film “Bad Blood: A Cautionary Tale,” will premiere Wednesday in New York City as the launch of a theatrical screening series co-hosted by a coalition of national gay rights and hemophilia advocacy...

Dr. Donohue suggests more Alpha-1 testing

Friday, July 23, 2010
A question today from the syndicated “Dr. Donahue” column DEAR DR. DONOHUE: My wife of 55 years died last year from the complications of an illness known as alpha-1 antitrypsin deficiency. In her late 40s, she would become unduly...

Patient advocacy group applauds new regulations to strengthen patients' right to appeal health insurance denials

Friday, July 23, 2010
Washington, DC—The National Health Council (NHC) today released a statement in support of today’s White House announcement of new federal regulations to strengthen patients’ rights to appeal health insurance denials. The Alpha-1...

Charles Leonard Geiger, MD, dies; father of well-known Alpha

Friday, July 16, 2010
GAINESVILLE, GA—Charles Leonard Geiger, MD, died Wednesday, July 14. A retired pathologist, he had formerly been an officer in the US Air Force Medical Service and professor of clinical pathology at Emory Medical School. He was the father...

Alpha-1 patient in Canada doing well after getting lung transplant despite infection with H1N1 (swine flu) virus

Wednesday, July 14, 2010
CBC News EDMONTON, Alberta—A 50-year-old Canadian with Alpha-1 Antitrypsin Deficiency underwent a successful double lung transplant last year in Edmonton even though he was infected with the H1N1 virus at the time of the surgery, doctors...

Iowa Alpha-1 education day August 28 features talks on importance of exercise, getting to positive, advocacy opportunities and More

Tuesday, July 6, 2010
DES MOINES, IA – Josh Stolpe, a Cardiopulmonary Specialist at Mercy Medical Center, will explain “The Importance of Exercise” at the Alpha-1 Education Day on August 28. Jeff Wilson, MD, Professor of Medicine at the University of...

FDA approves Kamada's IV drug Glassia as 4th US augmentation therapy for Alpha-1

Friday, July 2, 2010
Israeli biopharmaceutical company Kamada Inc. has been granted approval by the US Food and Drug Administration for Glassia, its intravenous augmentation therapy to treat emphysema due to Alpha-1 Antitrypsin Deficiency. Alpha-1 Antitrypsin...

Kathy Haduck receives Helen Chase Walsh Memorial Award

Thursday, June 17, 2010
AlphaNet Coordinator Kathy Haduck of Blandburg, PA, was honored with the Helen Chase Walsh Memorial Award at the recent annual education conference of the Alpha-1 Association in Orlando, FL. The award is presented each year by the Walsh family to...

Do you have the scoop on Alpha-1?

Thursday, June 17, 2010
Darin and Megan Chittick know exactly why it’s important to support Alpha-1 fundraisers. Their daughter, McKinley Chittick, who is now three years old, was diagnosed with Alpha-1 when she was just a month old. She developed severe jaundice...

$1 million donation by Cadwgans to help Alpha-1 Foundation "find new therapies and ultimately, a cure"

Wednesday, June 16, 2010
Ruth and Gordon E. Cadwgan, Jr., made a surprise announcement at this past weekend’s national education conference in Orlando: the donation of a million dollars to the Alpha-1 Foundation from themselves and Gordon Cadwgan, Sr. Gordon...

Foundation scientific director receives "outstanding investigator" award from Hungarian Respiratory Society

Wednesday, June 16, 2010
SOPRON, HUNGARY—Alpha-1 Foundation Scientific Director Adam Wanner, MD, recently received the “Outstanding Investigator Award” from the Hungarian Respiratory Society at its biennial meeting. Wanner gave the keynote speech at the...

Article Search

Enter keywords in text box and click Search button for results.